Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

Sissie Hsaio, the Google exec who oversaw the launch of the company’s AI chatbot, is stepping down as head of the Gemini app, ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

Google reshuffles AI leadership with Sissie Hsiao stepping down and Josh Woodward stepping in to drive Gemini's evolution.